Drreddys Laboratories | Beneficio Operativo



Operating Profit Cambio Fecha
ANI Pharmaceuticals USD 26.19M 30.57M 2025-03
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bayer EUR 2.32B 1.21B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Cipla INR 12.29B 4.8B 2025-03
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.72B 1.17B 2024-12
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Novartis USD 2.28B 1.34B 2024-12
Pacira USD 1.99M 22.71M 2025-03
Prestige Brands USD 88.43M 3.53M 2025-03
Richter Gedeon HUF 63.71B 2.25B 2024-09
Sun Pharmaceuticals INR 23.99B 8.46B 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Teva Pharmaceutical Industries USD 519M 64M 2025-03



Drreddys Laboratories Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.